Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Eyepoint Inc (EYPT)

Eyepoint Inc (EYPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Eyepoint Inc 480 PLEASANT STREET WATERTOWN MA 02472 USA

www.eyepointpharma.com Employees: 214 P: 617-926-5000 F: 617-926-5050

Sector:

Medical

Description:

EYEPOINT INC is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. EYEPOINT INC, formerly known as EyePoint Pharmaceuticals Inc., is based in WATERTOWN, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,070,432
Enterprise Value, $K 968,612
Shares Outstanding, K 83,432
Float, K 79,711
% Float 95.54%
Short Interest, K 10,869
Short Float 13.03%
Days to Cover 4.51
Short Volume Ratio 0.84
% of Insider Shareholders 4.46%
% of Institutional Shareholders 99.41%

Financials:

Annual Sales, $ 31,370 K
Annual Net Income, $ -231,960 K
Last Quarter Sales, $ 620 K
Last Quarter Net Income, $ -67,610 K
EBIT, $ -243,450 K
EBITDA, $ -245,970 K

Growth:

1-Year Return 95.11%
3-Year Return 336.39%
5-Year Return 18.69%
5-Year Revenue Growth -8.91%
5-Year Earnings Growth 8.65%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.81 on 03/04/26
Next Earnings Date 05/06/26
Earnings Per Share ttm -3.16
EPS Growth vs. Prev Qtr 4.71%
EPS Growth vs. Prev Year -26.56%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/09/20

EYPT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -88.31%
Return-on-Assets % -72.52%
Profit Margin % -739.43%
Debt/Equity 0.00
Price/Sales 35.19
Price/Cash Flow N/A
Price/Book 3.58
Book Value/Share 3.70
Interest Coverage -7,721.67
60-Month Beta 1.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.